Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Elder Pharma has reported net sales of INR2.11bn for the second quarter ended 30 September 2010, compared to INR1.75bn for the comparable period in 2009.
Subscribe to our email newsletter
Elder Pharma has posted a net profit of INR135.38m for the second quarter 2010, compared to net profit of INR84.91m for the comparable period in 2009.
For the six months ended 30 September 2010, Elder Pharma has posted a revenue of INR4.05bn, compared to INR3.45bn for the year ago period.
For the six months ended 30 September 2010, net profit was INR295.62m, compared to INR173.43m for the year ago period.
Elder Pharma is engaged in the manufacture of a wide range of pharmaceutical product through research and development and also in the manufacturing and marketing of diverse products through licensing agreements with international pharmaceutical companies.